202 related articles for article (PubMed ID: 17296624)
1. Differential subcellular distribution of mitoxantrone in relation to chemosensitization in two human breast cancer cell lines.
Vibet S; Mahéo K; Goré J; Dubois P; Bougnoux P; Chourpa I
Drug Metab Dispos; 2007 May; 35(5):822-8. PubMed ID: 17296624
[TBL] [Abstract][Full Text] [Related]
2. Sensitization by docosahexaenoic acid (DHA) of breast cancer cells to anthracyclines through loss of glutathione peroxidase (GPx1) response.
Vibet S; Goupille C; Bougnoux P; Steghens JP; Goré J; Mahéo K
Free Radic Biol Med; 2008 Apr; 44(7):1483-91. PubMed ID: 18267129
[TBL] [Abstract][Full Text] [Related]
3. The effect of quercetin on topotecan cytotoxicity in MCF-7 and MDA-MB 231 human breast cancer cells.
Akbas SH; Timur M; Ozben T
J Surg Res; 2005 May; 125(1):49-55. PubMed ID: 15836850
[TBL] [Abstract][Full Text] [Related]
4. Differential sensitization of cancer cells to doxorubicin by DHA: a role for lipoperoxidation.
Mahéo K; Vibet S; Steghens JP; Dartigeas C; Lehman M; Bougnoux P; Goré J
Free Radic Biol Med; 2005 Sep; 39(6):742-51. PubMed ID: 16109304
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 Tat peptide immunoconjugates differentially sensitize breast cancer cells to selected antiproliferative agents that induce the cyclin-dependent kinase inhibitor p21WAF-1/CIP-1.
Hu M; Wang J; Chen P; Reilly RM
Bioconjug Chem; 2006; 17(5):1280-7. PubMed ID: 16984139
[TBL] [Abstract][Full Text] [Related]
6. Coenzyme Q0 induces apoptosis and modulates the cell cycle in estrogen receptor negative breast cancer cells.
Somers-Edgar TJ; Rosengren RJ
Anticancer Drugs; 2009 Jan; 20(1):33-40. PubMed ID: 18830129
[TBL] [Abstract][Full Text] [Related]
7. Tert-butyl-2(4,5-dihydrogen-4,4,5,5-tetramethyl-3-O-1H-imidazole-3-cationic-1-oxyl-2-pyrrolidine-1-carboxylic ester displays novel cytotoxicity through reactive oxygen species-mediated oxidative damage in MCF-7 and MDA-MB-231 cells.
Zhang Y; Guo J; Zeng L; Zhang J; Hui Y; Liu J; Qing X; Sun X; Guo G
Chem Biol Interact; 2011 Jul; 192(3):287-97. PubMed ID: 21536016
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis induced by intracellular ceramide accumulation in MDA-MB-435 breast carcinoma cells is dependent on the generation of reactive oxygen species.
Chan SY; Hilchie AL; Brown MG; Anderson R; Hoskin DW
Exp Mol Pathol; 2007 Feb; 82(1):1-11. PubMed ID: 16624283
[TBL] [Abstract][Full Text] [Related]
9. Defective repair of 8-hydroxyguanine in mitochondria of MCF-7 and MDA-MB-468 human breast cancer cell lines.
Mambo E; Nyaga SG; Bohr VA; Evans MK
Cancer Res; 2002 Mar; 62(5):1349-55. PubMed ID: 11888904
[TBL] [Abstract][Full Text] [Related]
10. Hyperglycemia-induced thioredoxin-interacting protein expression differs in breast cancer-derived cells and regulates paclitaxel IC50.
Turturro F; Von Burton G; Friday E
Clin Cancer Res; 2007 Jun; 13(12):3724-30. PubMed ID: 17575238
[TBL] [Abstract][Full Text] [Related]
11. Nuclear estrogen receptor targeted photodynamic therapy: selective uptake and killing of MCF-7 breast cancer cells by a C17alpha-alkynylestradiol-porphyrin conjugate.
Swamy N; Purohit A; Fernandez-Gacio A; Jones GB; Ray R
J Cell Biochem; 2006 Oct; 99(3):966-77. PubMed ID: 16741968
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic activity of 3,3',4,4',5,5'-hexahydroxystilbene against breast cancer cells is mediated by induction of p53 and downregulation of mitochondrial superoxide dismutase.
Murias M; Luczak MW; Niepsuj A; Krajka-Kuzniak V; Zielinska-Przyjemska M; Jagodzinski PP; Jäger W; Szekeres T; Jodynis-Liebert J
Toxicol In Vitro; 2008 Aug; 22(5):1361-70. PubMed ID: 18434081
[TBL] [Abstract][Full Text] [Related]
13. Involvement of PPARalpha in the growth inhibitory effect of arachidonic acid on breast cancer cells.
Bocca C; Bozzo F; Martinasso G; Canuto RA; Miglietta A
Br J Nutr; 2008 Oct; 100(4):739-50. PubMed ID: 18304389
[TBL] [Abstract][Full Text] [Related]
14. beta-Sitosterol enhances tamoxifen effectiveness on breast cancer cells by affecting ceramide metabolism.
Awad AB; Barta SL; Fink CS; Bradford PG
Mol Nutr Food Res; 2008 Apr; 52(4):419-26. PubMed ID: 18338406
[TBL] [Abstract][Full Text] [Related]
15. Anticancer SAR models for MCF-7 and MDA-MB-231 breast cell lines.
Qamar S; Carrasquer CA; Cunningham SL; Cunningham AR
Anticancer Res; 2011 Oct; 31(10):3247-52. PubMed ID: 21965732
[TBL] [Abstract][Full Text] [Related]
16. Sequence-dependent administration of 5-fluorouracil maintains methotrexate antineoplastic activity in human estrogen-negative breast cancer and protects against methotrexate cytotoxicity in human bone marrow.
Das JR; Fryar-Tita EB; Zhou Y; Green S; Southerland WM; Bowen D
Anticancer Res; 2007; 27(6B):3791-9. PubMed ID: 18225534
[TBL] [Abstract][Full Text] [Related]
17. The role of Ca2+ in baicalein-induced apoptosis in human breast MDA-MB-231 cancer cells through mitochondria- and caspase-3-dependent pathway.
Lee JH; Li YC; Ip SW; Hsu SC; Chang NW; Tang NY; Yu CS; Chou ST; Lin SS; Lino CC; Yang JS; Chung JG
Anticancer Res; 2008; 28(3A):1701-11. PubMed ID: 18630529
[TBL] [Abstract][Full Text] [Related]
18. WRC-213, an l-methionine-conjugated mitoxantrone derivative, displays anticancer activity with reduced cardiotoxicity and drug resistance: identification of topoisomerase II inhibition and apoptotic machinery in prostate cancers.
Hsiao CJ; Li TK; Chan YL; Hsin LW; Liao CH; Lee CH; Lyu PC; Guh JH
Biochem Pharmacol; 2008 Feb; 75(4):847-56. PubMed ID: 18035333
[TBL] [Abstract][Full Text] [Related]
19. [Radiosensitizing effect of conjugated linoleic acid on tumor cells MCF-7 and MDA-MB-231].
Drouin G; Douillette A; Lacasse P; Paquette B
Can J Physiol Pharmacol; 2004 Feb; 82(2):94-102. PubMed ID: 15052290
[TBL] [Abstract][Full Text] [Related]
20. Quantitative and qualitative effect of gH625 on the nanoliposome-mediated delivery of mitoxantrone anticancer drug to HeLa cells.
Perillo E; Allard-Vannier E; Falanga A; Stiuso P; Vitiello MT; Galdiero M; Galdiero S; Chourpa I
Int J Pharm; 2015 Jul; 488(1-2):59-66. PubMed ID: 25891256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]